During the same period, five EBM systems were delivered (compared to 3 in 2012) and the company formed a strategic alliance with DiSanto Technology Inc.
“The strong growth in the second half of 2012 continues, and during the first 9 months of 2013 the turnover increased by 73% and the net result was improved significantly, compared to the same period 2012,” said Magnus René, Arcam president & CEO. “The strong order intake continues with 17 machine orders in the period, compared with 12 machine orders in the same period of 2012. Trailing 12 month machine orders is 29 systems. The aftermarket is developing well, and aftermarket sales in the period were SEK46.0 million. [...]
“In February, a strategic partnership was formed with the contract manufacturer DiSanto Technology Inc. (DTI) in the U.S. The partnership gives Arcam the ability to offer existing and new customers contract manufacturing of advanced orthopedic implants based on the Arcam EBM technology.
“Arcam has high ambitions in two very demanding markets," René said. "While both system and aftermarket sales are increasing rapidly and with good margins, increased turnover and activity will require a larger working capital. With a strong financial position, we also have the possibility to exercise the option to acquire DiSanto Technologies.”
